摘要
尘肺病是长期吸入带电荷的粉尘粒子从而导致肺部一系列损伤的疾病,这一系列损伤包括直接的肺部损伤,形成活性化学物质产生细胞因子和化学因子,诱导肺部纤维化以及诱导细胞凋亡等。临床上根据不同的分期及致病机制先后开发出了一系列相关药物及治疗方案。本文综述了近年来药物治疗尘肺病的最新进展,以期为临床治疗尘肺以及药物研发提供相关参考资料。
Pneumoconiosis is a disease induced by long-term inhalation of charged dust particles and caused a series of damage to the lungs.This series of injuries included direct lung injury,formation of reactive chemicals,cytokines,and pulmonary fibrosis,and induction of apoptosis.Many drugs and treatment programs have been developed based on different stages and pathogenic mechanisms.This article reviewed the recent advances in the pharmacological treatment of pneumoconiosis to provide references for the clinical treatment of pneumoconiosis and drug development.
作者
张永红
张晨宁
郑涛
马卫东
陈黎
ZHANG Yong-hong;ZHANG Chen-ning;ZHENG Tao;MA Wei-dong;CHEN Li(Institute of WudangTraditional Chinese Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan Hubei 442000;School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 102488)
出处
《中南药学》
CAS
2019年第7期1051-1055,共5页
Central South Pharmacy
基金
国家自然科学基金青年基金(No.81703582)
湖北省自然科学基金(No.2016CFB153)
太和医院博士科研启动基金(No.2016BSQD03和2016BSQD05)
太和医院科研项目(No.2017JJXM074)
关键词
尘肺病
致病机制
药物治疗
进展
pneumoconiosis
pathogenic mechanism
pharmacotherapy
progress